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pen accessAbstract Background: Thoracic paravertebral block (TPVB) is an effective intraoperative and
postoperative technique for surgical anaesthesia and analgesia for breast surgery. It offers a
long-lasting effective analgesia without increases in side effects, with a signiﬁcant decrease in anaes-
thetic and analgesic consumption, and with a high degree of patient satisfaction and shorter recov-
ery time. In this study, TPVB was done by using a nerve stimulator to measure the depth of needle
insertion by eliciting intercostal muscle contraction, and a catheter was introduced preoperatively to
allow for repeated injections and to maintain analgesia postoperatively.
Methods: Two groups of patients undergoing unilateral cancer breast surgery (each 20 patients)
were randomly assigned to the study; a study group (PVB) and a control (C) group. The study
started by preoperative application of an epidural catheter by using the nerve stimulator at the
fourth thoracic paravertebral space in the study group and injection of local anaesthetic started pre-
operatively. General anaesthesia was started for the two groups. Total intraoperative fentanyl and
postoperative morphine consumption, and pain intensity at rest and with arm movement were
recorded, together with recording of any undesirable side effects for 24 h.
Results: There were statistically highly signiﬁcant decreases in intraoperative fentanyl consumption
and postoperative morphine consumption in the PVB group than the C group. There were statisti-
cally signiﬁcant decreases in the VAS in the PVB group than the C group both at rest and with
shoulder movement. The incidence of adverse events was very low in both groups.m
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84 J.M. Kamal Abdel-halimConclusion: Continuous TPVB provides effective pain relief, signiﬁcant opioid sparing, and also
less painful restricted movement of the shoulder, with few side effects after breast cancer surgery.
Thoracic paravertebral somatic nerve block may be an alternative to general anaesthesia for major
unilateral breast surgery with heavy sedation or to be combined with light general anaesthesia.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Thoracic paravertebral block (TPVB) is becoming increasingly
popular, especially as an anaesthetic adjunct for breast sur-
gery. The best anaesthetic technique for breast cancer surgery
allows for good intraoperative and postoperative analgesia
with early hospital discharge. Breast cancer surgery with axil-
lary dissection is usually performed under general anaesthesia.
TPVB is an effective intraoperative and postoperative tech-
nique for surgical anaesthesia and analgesia for breast surgery.
It offers a long-lasting effective analgesia without increases in
side effects, with a signiﬁcant decrease in anaesthetic and anal-
gesic consumption, and with a high degree of patient satisfac-
tion and shorter recovery time [1–4].
Thoracic paravertebral block (TPVB) is the technique of
injecting local anaesthetic adjacent to the thoracic vertebra
close to where the spinal nerves emerge from the intervertebral
foramina. This results in ipsilateral somatic and sympathetic
nerve blockade in multiple contiguous thoracic dermatomes
above and below the site of injection [2].
In this study, TPVB was done by using a nerve stimulator
to measure the depth of needle insertion by eliciting intercostal
muscle contraction, and a catheter was introduced preopera-
tively to allow for repeated injections and to maintain analge-
sia postoperatively. TPVB was evaluated for its intraoperative
anaesthesia and analgesia and postoperative analgesic effect in
patients undergoing breast cancer surgery with recording of
the intraoperative and postoperative narcotic consumption
and any untoward side effects.2. Patients and methods
The study was obtained after our institutional review board,
and after giving written, informed consent from the participat-
ing patients in this randomized, prospective, single-blinded
study. Forty patients, classiﬁed as ASA physical status I–II,
aged 18–60 years, were scheduled for unilateral breast surgery;
either wide local excisions (at least one breast quadrant) with
axillary dissection, or modiﬁed radical mastectomies.
Patients were randomly divided into two groups, paraverte-
bral block group (PVB group) in which patients were candi-
dates for general anaesthesia after thoracic paravertebral
catheter application and local anaesthetic injection, and the
control C group were candidates for general anaesthesia. Pa-
tient exclusion criteria included patient refusal, coagulopathy,
infection at the site of block placement, chest deformity,
obstructive or restrictive lung disease, morbid obesity (twice
the ideal body weight or >130 kg), and sensitivity to local
anaesthetics.
The study started in the preoperative holding area. Patients
were instructed in the use of the 100 mm visual analogue score
(VAS): a pain VAS (0 = no pain to 100 = worst imaginable
pain). Sedation was achieved for patients for TPVB with intra-venous midazolam 1–5 mg, while the patients were in the lateral
left decubitus position. Blood pressure, ECG, and oxygen sat-
uration were monitored, and an oxygen face mask 3 L min1
was applied. The injection site was marked 2.5 cm laterally to
the midline determined by manual palpation (spinous process
of T4) ipsilateral to the operative breast. After aseptic prepara-
tion of the skin, the injection site was inﬁltrated with lidocaine
1% 1–2 ml. A 10 cm 21 G insulated needle (Stimuplex, B.
Braun, Melsungen, Germany), attached to a nerve stimulator
(initial stimulating current: 5 mA, 1 Hz, 9 V; Stimuplex, B.
Braun) was introduced perpendicularly to the skin. After pierc-
ing the costo-transverse ligament, a proper muscular response
of the intercostal muscles of the corresponding level was ob-
tained and the needle’s tip was manipulated into a position
allowing a muscular response while reducing the stimulating
current to 0.4–0.6 mA, and the depth was then measured. The
insulated needle was then removed and an 18 G Tuohy needle
(Periﬁx, B. Braun Melsungen AG) was introduced at the same
point and at the same depth previously measured. Even if inad-
vertent hitting of spinous process occurred (especially in obese
patients), the distance was measured, and a Tuohy needle was
advanced perpendicularly in the same track to hit the spinous
process at the same depth previously measured, then with-
drawn and redirected more caudad until it slips off of the trans-
verse process, it was then advanced anteriorly and laterally
approximately 1–1.5 cm. Loss of resistance by saline was done
to conﬁrm the space and to make catheter introduction easier.
After negative aspiration of blood, air or cerebrospinal ﬂuid, a
standard epidural catheter was introduced cephalad and placed
4–5 cm into the space, and then ﬁxed to the skin and the patient
was then returned to the supine position. A bolus study dose of
2% lidocaine with adrenaline (1:200000) 5 ml was injected with
monitoring of the conscious level, heart rate and blood pres-
sure, to exclude spinal or epidural injection or pneumothorax;
and the remaining 15 ml was injected after 5 min with aspira-
tion, with injecting 5 ml every 5 min. Sensory loss was assessed
by the loss of pin-prick sensation at the dermatomal distribu-
tion of the root being blocked ﬁrst, then the sensory extent of
the block was assessed later above and below the level of cath-
eter introduction. After assuring adequate anaesthesia, and the
patient was vitally stable, without any manifestations of local
anaesthetic toxicity, the patient was transferred to the operat-
ing room. Midazolam, 2–5 mg, was given to patients of the C
group.
General anaesthesia was then started, by the anaesthetist
without identiﬁcation of the patients with TPVB, to both the
study group and the control group with intravenous fentanyl
100 lg and propofol 2–3 mg kg1, and intubation was facili-
tated by atracurium 5 mg kg1. Anaesthesia was maintained
with isoﬂurane 1–1.5% in oxygen and mechanical ventilation.
Heart rate and mean arterial blood pressure (MAP) were main-
tained within ±20% of the preoperative baseline, and IV bolus
doses of fentanyl approximately 1 lg/kg were given if the MAP
or heart rate increased more than 20% of the baseline.
Table 1 Patients’ characteristics and time of surgery and
anaesthesia (min), values are expressed as mean ± SD.
PVB Group (n= 20) C Group (n= 20)
Age (years) 51 ± 12 49 ± 13
Weight (kg) 72 ± 14 73 ± 11
ASA I/II (number) 13/7 15/5
Time of surgery (min) 112 ± 26 117 ± 23
Time of anaesthesia (min) 154.5 ± 25* 129.7 ± 24
* Means statistically signiﬁcant (P< 0.05).
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and stopping isoﬂurane, the patients were shifted to the pos-
tanaesthesia care unit PACU, and a resident unaware of the
anaesthetic technique collected postoperative patient data.
The anaesthesia time was recorded, starting from monitor
placement before the block till extubation in the study group,
and the time of surgery started from intraoperative monitor
placement until extubation.
The time at which the patients asked for the ﬁrst rescue for
analgesia was recorded, and a VAS pain score was recorded at
30 min, 1 h, 2 h, 4 h, 12 h, and 24 h. Analgesia for the control
group was provided with IV increments of 2–3 mg morphine
every 15 min until pain VAS score was <3, and a 5 ml bolus
dose of lidocaine 2% and an infusion of 1% lidocaine 5 ml/h
started for the patients in the PVB group. A 2–3 mg morphine
bolus was given if pain persisted for 15 min after the bolus
dose of lidocaine. The number of rescue doses of analgesia
during the 24 h study period was recorded, and the VAS pain
score was recorded at 30 min, 1 h, 2 h, 4 h, 12 h, and 24 h both
at rest and with shoulder movements. Total intraoperative fen-
tanyl dose administered and the total postoperative morphine
consumption for each patient were recorded.
Side effects, such as nausea and vomiting, hypotension,
respiratory complications as respiratory depression or pneu-
mothorax, or local anaesthetic toxicity were recorded.
2.1. Statistical analysis
Quantitative data were expressed as mean ± standard devia-
tion (SD). Unpaired Student’s t-tests or two-way analysis of
variance (ANOVA) test was used for variable differences in
groups, and Bonferroni correction tests were used for correc-
tion of multiple comparisons. Categorical data were analysed
using v2-test analysis or the Fisher Exact test, as appropriate.
Statistical signiﬁcance was deﬁned as P< 0.05.
4. Results
All patients completed the study, there were no statistical dif-
ferences between the two groups regarding the age, weight, and
ASA physical status. No statistical differences in the time of
surgery, but the time of anaesthesia was increased signiﬁcantly
in the PVB group than the control group due to adding the
time of block Table 1.Table 2 Intraoperative narcotic consumption, the ﬁrst time to
request for analgesia, and the number of times for requesting
analgesia, values are expressed as mean ± SD.
PVB Group
(n= 20)
C Group
(n= 20)
Intraoperative fentanyl
consumption (lg)
132 ± 47** 193 ± 39
Postoperative morphine
consumption (mg)
5.3 ± 2.8** 10.4 ± 3.9
Time for requesting ﬁrst
analgesia (min)
176.7 ± 146.5** 37.4 ± 20.6
Number of rescue doses
of analgesia in 24 h
0.8 ± 1** 3.2 ± 0.8
** Means highly signiﬁcant decreases (p< 0.01).There were highly signiﬁcant decreases (p< 0.01) in both
intraoperative fentanyl consumption and postoperative mor-
phine consumption in the PVB group than the control group.
There was also signiﬁcant decrease in the number of patients
who requested for analgesia and in the number of the boluses
of morphine given on patient’s request Table 2.
At rest, there were statistically signiﬁcant decreases in the
VAS in the PVB group than the C group (P< 0.05) at
30 min, 1 h, 2 h, 4 h, and 8 h. With shoulder movement, VAS
was signiﬁcantly lower in the PVB group than the C group
at all times recorded. The decrease was highly signiﬁcant
(p< 0.01) at 1 h, 2 h, and 4 h at rest and with shoulder move-
ment. In three patients in the PVB group, the loss of pin-brick
sensation was not evident with increases of the intraoperative
fentanyl and postoperative morphine consumption (failure
rate 15%) (Fig. 1).
There were no major adverse events in either group requir-
ing intervention in the operating room or in the PACU. No
symptoms or signs of local anaesthetic toxicity, or pneumotho-
rax were recorded in any patient after TPVB. The incidence of
nausea and vomiting was lower in the TPVB (2/20) than the
control group (4/20) but not statistically signiﬁcant.
5. Discussion
The results of this study showed that TPVB with catheter
application provides improvement in intraoperative and post-
operative analgesia, less need for intraoperative and postoper-
ative opioid analgesics, and without increases in side effects for
patients who were candidates for major breast cancer surgery
when compared to control group of patients under general
anaesthesia.
TPVB is an old technique which was described by Hugo
Sellheim in 1905, who used the technique to produce abdomi-
nal analgesia. TPVB was neglected until 1979, when Eason and
Wyatt described a catheter technique [5].
The thoracic paravertebral space (TPVS) is a wedge-shaped
space that lies on either side of the vertebral column. The pari-
etal pleura forms the anterolateral boundary, while the base is
formed by the posterolateral aspect of the vertebral body, the
intervertebral disc, the intervertebral foramen and its contents.
The superior costotransverse ligament, which extends from the
lower border of the transverse process above to the upper bor-
der of the transverse process below, forms the posterior wall of
the TPVS. The apex of the space is continuous, with the inter-
costal space lateral to the tips of the transverse processes [2,4].
A thoracic paravertebral injection may remain localized to
the level injected, or it may spread to the contiguous levels
(A)VAS score at rest
0
5
10
15
20
25
30
35
40
45
50
30min 1hr 2hr 4hr 8hr 12hr 24hr 30min 1hr 2hr 4hr 8hr 12hr 24hr
Time
VA
S 
sc
or
e(
0-
10
0) PVB group
C group
(B)VAS score with movement
0
10
20
30
40
50
60
70
80
Time
VA
S 
sc
or
e 
(0
-1
00
)
PVB group
C group
Figure 1 Postoperative visual analogue score (VAS) changes (A) at rest and (B) with movement.
86 J.M. Kamal Abdel-halimabove and below, the intercostal space laterally, the epidural
space medially, or a combination of the above to affect ipsilat-
eral somatic and sympathetic nerves. It was evidenced that a
mean distribution of the somatic block of ﬁve dermatomes,
by loss of pinprick sensation, the mean distribution of the sym-
pathetic block was eight epsilateral dermatomes by thermo-
graphic imaging [2,4–6].
TPVB is technically easy to learn and perform, could be
done in awake sedated patient. The failure rate in the study
was 15%, which is high probably due to the small number of
patients and due to catheter application.
The failure rate varies from 6.1% to 10% in other studies,
which was comparable with that of other used regional anaes-
thetic techniques and reﬂects the technical difﬁculty in identi-
fying the TPVS [4,7,8].
Many approaches have been described. The classical tech-
nique, which was most commonly used, involves eliciting loss
of resistance by air or saline as the superior costotransverse lig-
ament is traversed. Using loss of resistance technique is subjec-
tive and may be misleading. In this study, TPVB was made
easier and safer by knowing the depth of the space before nee-
dle insertion by the use of nerve stimulator. It could be used in
awake sedated patients, but in some obese patients the re-
sponse may not appear and the patient must be asked about
sensation of muscle contraction [2,4].
Lang and Scott in 2002 and Boezaart et al. in 2006 reported
that the use of nerve stimulator is simple and allows precise
correlations to be made between anatomy, physiology (motor
responses, electrically elicited paraesthesiae, and reproduction
of pain in the targeted dermatome/s) and clinical effect. Also it
does offer some additional degree of safety [9,10].
Lidocaine with adrenaline was used in this study to increase
safety of using large doses and to avoid the marcain’s cardio-
toxicity, especially with the presence of catheter. Lidocaine was
proved to be an attractive alternative to marcaine in TPVB in
children for its shorter elimination half-life and lower cardio-
toxicity [11].
TPVB by injection of local anaesthetic at a single level at T4
or at multiple levels in conjunction with heavy sedation or with
general anaesthesia was evaluated for a long time for anaesthe-
sia in breast surgery. It was found to be effective and safe for
anaesthesia and postoperative analgesia, with a high degree of
patient satisfaction and minimal complications. TPVB resulted
in better postoperative pain control and earlier resumption of
diet compared with general anaesthesia. Single or multiple
injections techniques are limited by the duration of the localanaesthetic; and multilevel injections have deﬁnitely another
disadvantage for a technique that requires positioning and
multiple injections [3,12–18].
The use of paravertebral catheter to provide long-lasting
analgesia has been described in adults and children, for breast
surgery, and for other surgeries [19,20]. In this study, catheter
application was very effective in postoperative analgesia and in
reduction of the analgesics used. It also provides safety in local
anaesthetic administration as multiple small bolus doses. The
potential problems with TPVB with catheter application are
intrapleural catheter placement and subarachnoid or epidural
injection. These complications were not recorded, due to the
adherence to the anatomical study, the use of nerve stimulator,
multiple aspirations and injections, with good patient
monitoring.
Recently, fentanyl or clonidine was added to diluted levo-
bupivacaine with intra- and postoperative paravertebral anal-
gesia in patients undergoing breast surgery under general
anaesthesia. Other studies were done to assess the efﬁcacy
and ability to use a patient-controlled paravertebral analgesia
for breast cancer surgery, and satisfactory analgesia was pro-
vided [21,22].
The paravertebral block has been used successfully for
analgesia in surgeries other than breast surgery as abdominal
operations, hepatic surgery and thoracic surgery. TPVB was
proved to be effective for analgesia for fracture ribs, penetrat-
ing trauma and for patients with post-herpetic neuralgia
refractory to medical therapy. [4,23–26].
Naja et al [8] looked at complications of PVB following
thoracic and lumbar paravertebral blocks performed in 620
adults and 42 children. The complications recorded were: inad-
vertent vascular puncture (6.8%); hypotension (4.0%); haema-
toma (2.4%); pain at site of skin puncture (1.3%); signs of
epidural or intrathecal spread (1.0%); pleural puncture
(0.8%); pneumothorax (0.5%).
Few side effects appear after TPVB, nearly similar to those
in the patients of the control group. We found no evidence of
local anaesthetic toxicity in any patients of the study group.
Also, hypotension was not recorded with the block for any
of the patients in the study. Hypotension was reported to be
not common in other studies after TPVB in normovolemic pa-
tients because of unilateral sympathetic blockade [2,4,8].
The technique of paravertebral block sometimes does not
gain acceptance because of requirement of more preoperative
time for catheter insertion and block. This was clear in this
study by the signiﬁcant increase in the time of anaesthesia in
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be solved by the early starting of the block before the opera-
tion starting time in the monitored holding area.
Because the paravertebral space lies adjacent to the inter-
vertebral foramina, inadvertent spread into the epidural space
may occur, the ﬁrst small bolus dose with monitoring of anaes-
thesia to the other side and monitoring of pulse rate and blood
pressure is very essential. Further, aspiration before injection is
also mandatory because the space contains vascular structures.
The most serious complication of the technique of thoracic
PVB is the potential occurrence of pneumothorax by deep nee-
dle penetration. If pneumothorax is not a possibility, as after
thoracotomy in which chest drains are placed for all cases,
lung disease may be a strong indication for thoracic paraverte-
bral block to promote breathing [2,4,8]
This complication was not present in the study by the ben-
eﬁcial use of the nerve stimulator to evaluate the depth of the
block without inadvertent deep penetration and pleural injury.
6. Conclusion
Thoracic paravertebral block is a simple, easy-to-learn tech-
nique with few contraindications and is associated with a
low incidence of complications. Continuous TPVB provides
effective pain relief, signiﬁcant opioid sparing, and also causes
less painful restricted movement of the shoulder, with very few
side effects after breast cancer surgery. Thoracic paravertebral
somatic nerve block may be an alternative to general anaesthe-
sia for major unilateral breast surgery with heavy sedation or
to be combined with light general anaesthesia.References
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